{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T20:21:38Z","timestamp":1775247698550,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,12,30]],"date-time":"2018-12-30T00:00:00Z","timestamp":1546128000000},"content-version":"am","delay-in-days":332,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DA019497"],"award-info":[{"award-number":["R01DA019497"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32DA07209"],"award-info":[{"award-number":["T32DA07209"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.jsat.2017.04.012","type":"journal-article","created":{"date-parts":[[2017,4,20]],"date-time":"2017-04-20T00:01:26Z","timestamp":1492646486000},"page":"38-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Predictors of induction onto extended-release naltrexone among unemployed heroin-dependent adults"],"prefix":"10.1016","volume":"85","author":[{"given":"Brantley P.","family":"Jarvis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"August F.","family":"Holtyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meredith S.","family":"Berry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shrinidhi","family":"Subramaniam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6153-5680","authenticated-orcid":false,"given":"Annie","family":"Umbricht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Fingerhood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George E.","family":"Bigelow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2017.04.012_bb0005","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3109\/00952990.2015.1106550","article-title":"Decision-making processes as predictors of relapse and subsequent use in stimulant-dependent patients","volume":"42","author":"Adinoff","year":"2015","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.jsat.2017.04.012_bb0010","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.4088\/JCP.09m05807","article-title":"Risk-taking propensity as a predictor of induction onto naltrexone treatment for opioid dependence","volume":"73","author":"Aklin","year":"2012","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jsat.2017.04.012_bb0015","author":"Alkermes"},{"key":"10.1016\/j.jsat.2017.04.012_bb0020","series-title":"Manual for the Beck Depression Inventory-II","author":"Beck","year":"1996"},{"key":"10.1016\/j.jsat.2017.04.012_bb0025","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.drugalcdep.2011.10.018","article-title":"Opioid challenge evaluation of blockade by extended-release naltrexone in opioid-abusing adults: Dose-effects and time-course","volume":"123","author":"Bigelow","year":"2012","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2017.04.012_bb0030","doi-asserted-by":"crossref","DOI":"10.1186\/1940-0640-7-3","article-title":"Return to drug use and overdose after release from prison: A qualitative study of risk and protective factors","volume":"7","author":"Binswanger","year":"2012","journal-title":"Addiction Science & Clinical Practice"},{"key":"10.1016\/j.jsat.2017.04.012_bb0035","doi-asserted-by":"crossref","first-page":"592","DOI":"10.7326\/0003-4819-159-9-201311050-00005","article-title":"Mortality after prison release: Opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009","volume":"159","author":"Binswanger","year":"2013","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.jsat.2017.04.012_bb0040","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jsat.2014.01.005","article-title":"A placebo-controlled trial of memantine as an adjunct to injectable extended-release naltrexone for opioid dependence","volume":"46","author":"Bisaga","year":"2014","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2017.04.012_bb0045","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.drugalcdep.2015.05.013","article-title":"The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone","volume":"154","author":"Bisaga","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2017.04.012_bb0050","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.4088\/JCP.09m05080ecr","article-title":"Long-acting injectable versus oral naltrexone maintenance therapy with psychosocial intervention for heroin dependence: A quasi-experimental experiment","volume":"71","author":"Brooks","year":"2010","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jsat.2017.04.012_bb0055","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0376-8716(96)01249-5","article-title":"Comparing assessments of DSM-IV substance dependence disorders using CIDI-SAM and SCAN","volume":"41","author":"Compton","year":"1996","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2017.04.012_bb0060","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/HRP.0000000000000075","article-title":"Medication-assisted treatment of opioid use disorder: Review of the evidence and future directions","volume":"23","author":"Connery","year":"2015","journal-title":"Harvard Review of Psychiatry"},{"key":"10.1016\/j.jsat.2017.04.012_bb0065","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1080\/08897077.2015.1052868","article-title":"A demonstration project implementing extended-release naltrexone in Los Angeles County","volume":"37","author":"Cousins","year":"2016","journal-title":"Substance Abuse"},{"key":"10.1016\/j.jsat.2017.04.012_bb0070","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jsat.2016.07.014","article-title":"A naturalistic evaluation of extended-release naltrexone in clinical practice in Missouri","volume":"70","author":"Crits-Cristoph","year":"2016","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2017.04.012_bb0075","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.drugalcdep.2011.06.023","article-title":"Employment-based reinforcement of adherence to an FDA approved extended release formulation of naltrexone in opioid-dependent adults: A randomized controlled trial","volume":"120","author":"DeFulio","year":"2012","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2017.04.012_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2011.05.033","article-title":"The association between outpatient buprenorphine detoxification duration and clinical treatment outcomes: A review","volume":"119","author":"Dunn","year":"2011","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2017.04.012_bb0085","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1037\/a0030743","article-title":"Employment-based reinforcement of adherence to oral naltrexone treatment in unemployed injection drug users","volume":"21","author":"Dunn","year":"2013","journal-title":"Experimental and Clinical Psychopharmacology"},{"key":"10.1016\/j.jsat.2017.04.012_bb20170","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jsat.2015.07.005","article-title":"A phase 4, pilot, open-label study of VIVITROL (extended-release naltrexone XR-NTX) for prisoners","volume":"59","author":"Gordon","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2017.04.012_bb0090","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1001\/jama.2015.11859","article-title":"Nonmedical prescription opioid use and use disorders among adults aged 18 through 64 years in the United States, 2003\u20132013","volume":"314","author":"Han","year":"2015","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.jsat.2017.04.012_bb0095","series-title":"Wisconsin card sorting test manual: Revised and expanded","author":"Heaton","year":"1993"},{"key":"10.1016\/j.jsat.2017.04.012_bb0100","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000141641","article-title":"Post-treatment outcomes of buprenorphine detoxification in community settings: A systematic review","volume":"14","author":"Horspool","year":"2008","journal-title":"European Addiction Research"},{"key":"10.1016\/j.jsat.2017.04.012_bb0105","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1037\/1064-1297.16.3.264","article-title":"An algorithm for identifying nonsystematic delay-discounting data","volume":"16","author":"Johnson","year":"2008","journal-title":"Experimental and Clinical Psychopharmacology"},{"key":"10.1016\/j.jsat.2017.04.012_bb0110","first-page":"719","article-title":"Vital signs: Demographic and substance use trends among heroin users \u2013 United States, 2002\u20132013","volume":"64","author":"Jones","year":"2015","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.jsat.2017.04.012_bb0115","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1056\/NEJMoa1505409","article-title":"Extended-release naltrexone to prevent opioid relapse in criminal justice offenders","volume":"374","author":"Lee","year":"2016","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.jsat.2017.04.012_bb0120","first-page":"75","article-title":"Evaluation of a behavioral measure of risk taking: The Balloon Analogue Risk Task (BART)","volume":"8","author":"Lejuez","year":"2002","journal-title":"Journal of Experimental Psychology: Applied"},{"key":"10.1016\/j.jsat.2017.04.012_bb0125","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.drugalcdep.2014.02.002","article-title":"Extended release naltrexone injection is performed in the majority of opioid dependent patients receiving outpatient induction: A very low dose naltrexone and buprenorphine open label trial","volume":"138","author":"Mannelli","year":"2014","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2017.04.012_bb0130","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1037\/1064-1297.13.4.293","article-title":"Predictors of outcomes in LAAM, buprenorphine, and methadone treatment for opioid dependence","volume":"13","author":"Marsch","year":"2005","journal-title":"Experimental and Clinical Psychopharmacology"},{"key":"10.1016\/j.jsat.2017.04.012_bb0135","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/00005053-198507000-00005","article-title":"New data from the Addiction Severity Index: Reliability and validity in three centers","volume":"173","author":"McLellan","year":"1985","journal-title":"The Journal of Nervous and Mental Disease"},{"key":"10.1016\/j.jsat.2017.04.012_bb0140","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/ajad.12180","article-title":"Baseline characteristics of patients predicting suitability for rapid naltrexone induction","volume":"24","author":"Mogali","year":"2014","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.jsat.2017.04.012_bb0145","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1901\/jeab.2001.76-235","article-title":"Area under the curve as a measure of discounting","volume":"76","author":"Myerson","year":"2001","journal-title":"Journal of the Experimental Analysis of Behavior"},{"key":"10.1016\/j.jsat.2017.04.012_bb0150","author":"National Institute on Drug Abuse"},{"key":"10.1016\/j.jsat.2017.04.012_bb0155","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1037\/tps0000061","article-title":"The therapeutic utility of employment in drug addiction: Science to application","volume":"2","author":"Silverman","year":"2016","journal-title":"Translational Issues in Psychological Science"},{"key":"10.1016\/j.jsat.2017.04.012_bb0160","first-page":"176","article-title":"Lapse and relapse following inpatient treatment of opiate dependence","volume":"103","author":"Smyth","year":"2010","journal-title":"Irish Medical Journal"},{"key":"10.1016\/j.jsat.2017.04.012_bb0165","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jsat.2014.08.007","article-title":"Delay discounting, treatment motivation and treatment retention among substance-dependent individuals attending an inpatient detoxification program","volume":"49","author":"Stevens","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2017.04.012_bb0170","author":"Substance Abuse and Mental Health Service Administration"},{"key":"10.1016\/j.jsat.2017.04.012_bb0175","author":"Substance Abuse and Mental Health Service Administration"},{"key":"10.1016\/j.jsat.2017.04.012_bb0180","doi-asserted-by":"crossref","DOI":"10.1176\/appi.ajp.2016.16050548","article-title":"Long-acting injectable naltrexone induction: A randomized trial of outpatient opioid detoxification with naltrexone versus buprenorphine","author":"Sullivan","year":"2017","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.jsat.2017.04.012_bb0185","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jsat.2016.02.009","article-title":"Patients' beliefs about medications are associated with stated preference for methadone, buprenorphine, naltrexone, or no medication-assisted therapy following inpatient opioid detoxification","volume":"66","author":"Uebelacker","year":"2016","journal-title":"Journal of Substance Abuse Treatment"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547216303713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547216303713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:48:01Z","timestamp":1760039281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547216303713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":38,"alternative-id":["S0740547216303713"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2017.04.012","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors of induction onto extended-release naltrexone among unemployed heroin-dependent adults","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2017.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}